Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 233,303,076 papers from all fields of science
Search
Sign In
Create Free Account
Receptor, Cannabinoid, CB1
Known as:
CB1 Receptor
, Receptor CB1, Cannabinoid
, Receptor, CB1
Expand
A subclass of cannabinoid receptor found primarily on central and peripheral NEURONS where it may play a role modulating NEUROTRANSMITTER release.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
CNR1 gene
In Blood
agonists
antagonists & inhibitors
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Evaluating AM1/d-CB1 for Chemical Glycobiology QM/MM Simulations.
K. Govender
,
K. Naidoo
Journal of Chemical Theory and Computation
2014
Corpus ID: 41107691
The newly parametrized AM1/d-CB1 is evaluated for its performance in modeling monosaccharide structure, carbohydrate ring pucker…
Expand
2013
2013
Molecular Basis of Cannabinoid CB 1 Receptor Coupling to the
J. Shim
,
K. Ahn
,
D. Kendall
2013
Corpus ID: 207857195
2010
2010
Cannabinoid CB1 receptor binding and acetylcholinesterase inhibitory activity of Sceletium tortuosum L.
S. Ehsan
2010
Corpus ID: 87193716
The whole plant extract of plant Sceletium tortuosum, plant native to South Africa, has been known traditionally to have mood…
Expand
2009
2009
The influence of ACEA--a selective cannabinoid CB1 receptor agonist on whole blood and platelet-poor plasma serotonin concentrations.
M. Rutkowska
,
H. Gliniak
Pharmazie
2009
Corpus ID: 36283834
Through the CB1 receptor cannabinoids modulate serotonin (5-hydroxytryptamine, 5-HT) release in the central nervous system which…
Expand
2008
2008
Play an ADAGIO with a STRADIVARIUS: the right patient for CB1 receptor antagonists?
V. Marzo
Nature Clinical Practice Cardiovascular Medicine
2008
Corpus ID: 28000363
Results of the STRADIVARIUS and ADAGIO-Lipids trials have fuelled debate about the use of the controversial CB1 receptor…
Expand
2007
2007
Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors
D. Centonze
,
S. Rossi
,
+6 authors
M. Maccarrone
European Journal of Neuroscience
2007
Corpus ID: 43243120
Behavioural studies indicate that cannabinoid receptors are implicated in cocaine addiction. The synaptic underpinning of cocaine…
Expand
2007
2007
Methoxy- and fluorine-substituted analogs of O-1302: synthesis and in vitro binding affinity for the CB1 cannabinoid receptor.
Shintaro Tobiishi
,
Toru Sasada
,
+4 authors
M. Maeda
Chemical and pharmaceutical bulletin
2007
Corpus ID: 40343622
Methoxy and fluorine analogs substituted on the terminal carbon of the pentyl chain of N-(piperidinyl)-1-(2,4-dichlorophenyl)-4…
Expand
2006
2006
3D-QSAR studies on cannabinoid CB1 receptor agonists: G-protein activation as biological data.
Outi M. H. Salo
,
Juha R. Savinainen
,
+6 authors
A. Poso
Journal of Medicinal Chemistry
2006
Corpus ID: 29889198
G-protein activation via the CB1 receptor was determined for a group of various CB1 ligands and utilized as biological activity…
Expand
2005
2005
Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in guinea-pig vessels, but not in rat and mouse aorta
T. Schultheiss
,
K. Flau
,
M. Kathmann
,
M. Göthert
,
E. Schlicker
Naunyn-Schmiedeberg's Archives of Pharmacology
2005
Corpus ID: 31752188
Cannabinoids exert complex effects on blood pressure related to their interference with cardiovascular centres in the central…
Expand
2005
2005
The novel cannabinoid agonist AM 411 produces a biphasic effect on accuracy in a visual target detection task in rats
P. J. McLaughlin
,
C. Brown
,
+4 authors
J. Salamone
Behavioural Pharmacology
2005
Corpus ID: 25782036
Cannabinoid agonists have been shown to produce dose-related impairments in several measures of cognitive performance. However…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE